Alphabet earnings on deck

A look ahead to Alphabet's earnings. And Aimmune Therapeutics jumps as the FDA approves its peanut allergy treatment. With CNBC's Tyler Mathisen and the Fast Money traders, Tim Seymour, Brian Kelly, Steve Grasso and Guy Adami.

Fast Money,CNBC,business news,finance stock,stock market,news channel,news station,breaking news,us news,world news,cable,cable news,finance news,money,money tips,financial news,stock market news,stocks,